Oil rose for a fourth straight session on Wednesday as the market shrugged off an industry report showing U.S. crude stockpiles rose more than expected, extending a rally driven by hopes that a COVID-19 vaccine will boost fuel demand.
Brent crude was up 74 cents, or 1.5%, at $48.60 a barrel by 1059 GMT, having risen almost 4% in the previous session.
West Texas Intermediate crude gained 58 cents, or 1.3%, to $45.49, after rising more than 4% on Tuesday.
“Crude oil prices are trading at their highest levels since early March, supported by positive market sentiment as a result of vaccine news and strong oil demand in Asia,” said UBS oil analyst Giovanni Staunovo.
“We maintain our bullish outlook for next year and target Brent to hit $60 per barrel at the end of 2021,” he added.
AstraZeneca said on Monday its COVID-19 vaccine was 70% effective in trials and could be up to 90% effective, providing another weapon in the fight to control the pandemic.
The formal start of U.S. president-elect Joe Biden’s transition to the White House has also improved the global outlook.
A weak dollar has also provided support for crude prices as a lower dollar makes oil less expensive for buyers.
“The recent depreciation of the U.S. dollar has helped temper the impact of surging oil prices for some of the world’s largest consumers of energy,” said Stephen Brennock of broker PVM.
Brent has moved into backwardation, a market structure in which oil for immediate delivery costs more than supply later. Backwardation encourages inventories to be drawn down.
The premium at which Brent crude futures for February delivery were trading above January stood at 13 cents, the highest level since July.